These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Treatment of arterial, peripheral and cerebral circulatory disorders. Clinical results using intravenous infusions of complamine]. Kunert W, Lietz W. Fortschr Med; 1972 Dec 21; 90(35):1315-7. PubMed ID: 4658025 [No Abstract] [Full Text] [Related]
7. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy]. Cascio F. Minerva Cardioangiol; 1973 Nov 21; 21(11):715-31. PubMed ID: 4776567 [No Abstract] [Full Text] [Related]
8. [Experiences with the treatment of peripheral vascular diseases with Xavin]. Brücknerová O. Vnitr Lek; 1973 Apr 21; 19(4):379-86. PubMed ID: 4699159 [No Abstract] [Full Text] [Related]
9. [Use of a xanthine derivative in peripheral arterial blood flow disorders]. de Weger WP. Med Monatsschr; 1970 May 21; 24(5):221-5. PubMed ID: 5512478 [No Abstract] [Full Text] [Related]
10. [Xanthinol-nicotinate (complamine)]. Cas Lek Cesk; 1968 May 21; 107(51):1567-8. PubMed ID: 5700857 [No Abstract] [Full Text] [Related]
11. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders]. Weber G, Vogel A. Dermatol Wochenschr; 1967 Nov 18; 153(46):1278-82. PubMed ID: 5588908 [No Abstract] [Full Text] [Related]
12. [The action of xanthinol nicotinate on the peripheral circulation of the aged]. Chevat H, Steenhouwer B, Hiltenbrand C, Legrand MF, Graux P. Angeiologie; 1968 Nov 18; 20(2):33-42. PubMed ID: 5682235 [No Abstract] [Full Text] [Related]
13. [Clinical experience with Complamine in vascular diseases of the fundus oculi]. Fronimopoulos J, Cofinas H, Lambrou N. Klin Monbl Augenheilkd; 1967 Nov 18; 151(2):201-7. PubMed ID: 5592110 [No Abstract] [Full Text] [Related]
14. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries]. Kiersnowska B, Bielawiec M, Lukjan H, Korfel B, Rogowski F, Dowzyk W. Pol Tyg Lek; 1973 Mar 12; 28(11):400-3. PubMed ID: 4694796 [No Abstract] [Full Text] [Related]
15. [Treatment of arteriopathies of limbs by xanthinol nicotinate]. Elbaz C. Phlebologie; 1969 Mar 12; 22(1):105-11. PubMed ID: 5775643 [No Abstract] [Full Text] [Related]
16. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases]. Bielawiec M, Lukjan H. Med Monatsschr; 1971 Jul 12; 25(7):312-4. PubMed ID: 5563915 [No Abstract] [Full Text] [Related]
17. [Cardilan in the treatment of obliterative diseases of peripheral arteries]. Ginko T, Adamczyk R, Dyaczyńska A. Wiad Lek; 1971 Jun 15; 24(12):1211-5. PubMed ID: 5561279 [No Abstract] [Full Text] [Related]
18. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy]. D'Ayala Valva G. Recenti Prog Med; 1966 Jun 15; 40(6):XIX-XXXVI. PubMed ID: 6014405 [No Abstract] [Full Text] [Related]
19. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate]. Jovino R, Renda A. Minerva Cardioangiol; 1971 Dec 15; 19(12):709-18. PubMed ID: 5129037 [No Abstract] [Full Text] [Related]
20. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative]. Kienholz E. Med Klin; 1965 Aug 13; 60(33):1321-4. PubMed ID: 5843335 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]